These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 21543340)
1. Aspirin and familial adenomatous polyposis: coming full circle. Chan AT Cancer Prev Res (Phila); 2011 May; 4(5):623-7. PubMed ID: 21543340 [TBL] [Abstract][Full Text] [Related]
2. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas. Asano TK; McLeod RS Cochrane Database Syst Rev; 2004; 2004(2):CD004079. PubMed ID: 15106236 [TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533 [TBL] [Abstract][Full Text] [Related]
4. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis]. Sheng JQ; Li SR; Yang XY; Zhang YH; Su H; Yu DL; Yan W; Geng HG Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):526-9. PubMed ID: 16681880 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention in familial adenomatous polyposis: past, present and future. Kemp Bohan PM; Mankaney G; Vreeland TJ; Chick RC; Hale DF; Cindass JL; Hickerson AT; Ensley DC; Sohn V; Clifton GT; Peoples GE; Burke CA Fam Cancer; 2021 Jan; 20(1):23-33. PubMed ID: 32507936 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial. Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492 [TBL] [Abstract][Full Text] [Related]
7. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial. Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627 [TBL] [Abstract][Full Text] [Related]
11. Chemoprevention with special reference to inherited colorectal cancer. Lynch PM Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350 [TBL] [Abstract][Full Text] [Related]
12. Celecoxib as adjunctive therapy for treatment of colorectal cancer. North GL Ann Pharmacother; 2001 Dec; 35(12):1638-43. PubMed ID: 11793634 [TBL] [Abstract][Full Text] [Related]
15. Effect of the non-steroidal anti-inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis. Matsumoto T; Nakamura S; Esaki M; Yao T; Iida M J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):251-7. PubMed ID: 16460482 [TBL] [Abstract][Full Text] [Related]
16. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Bowen CM; Walter L; Borras E; Wu W; Ozcan Z; Chang K; Bommi PV; Taggart MW; Thirumurthi S; Lynch PM; Reyes-Uribe L; Scheet PA; Sinha KM; Vilar E Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857 [TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. Thun MJ; Henley SJ; Patrono C J Natl Cancer Inst; 2002 Feb; 94(4):252-66. PubMed ID: 11854387 [TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review. Asano TK; McLeod RS Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679 [TBL] [Abstract][Full Text] [Related]
19. The protocol for a European double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: the CAPP study. Concerted Action Polyposis Prevention. Burn J; Chapman PD; Mathers J; Bertario L; Bishop DT; Bülow S; Cummings J; Phillips R; Vasen H Eur J Cancer; 1995; 31A(7-8):1385-6. PubMed ID: 7577057 [No Abstract] [Full Text] [Related]
20. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial. Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]